The Globe and Mail reports in its Friday, Aug. 4, edition that RBC Capital Markets analyst Walter Spracklin has reaffirmed his "sector perform" recommendation for Andlauer Healthcare Group. The Globe's David Leeder writes in the Eye On Equities column that Mr. Spracklin cut his share target to $45 from $46. Analysts on average target the shares at $53.36. Mr. Spracklin says in a note: "Andlauer Healthcare Group's financial results are reflecting the effects of normalization after a period of unsustainably higher revenue and margins during the pandemic. Stocks rarely fare well during periods of normalization as the Andlauer Healthcare shares, which had been largely range-bound in the $45 to $55 level for the past two years, have now come under pressure (down 17 per cent since May). The good news is that Q2 appears to reflect a new normalized run-rate. Attention will likely now turn to M&A and what form that may take. Note we have built M&A into our valuation and therefore see the shares as fully valued." The Globe reported on Nov. 11 and March 7 that Mr. Spracklin had reiterated his "sector perform" call for Andlauer when it could be had for $50.45 and $47.25.